CRYSTALLINE FORM OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-[(METHYL{[2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO]-4-(MORPHOLIN-4-YL)BUTANOYL 9AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE OR COBICISTAT

The invention provides a crystalline form of the compound of formula (Ia), methods for making the crystalline form of the compound of formula (Ia), and therapeutic methods for the use of the crystal line form of the compound of formula (Ia). L'invention concerne une forme cristalline du composé...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	YU, Lok Him Lawrence, LAI, Chiajen, YU, Richard Hung Chiu
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	YU, Lok Him Lawrence LAI, Chiajen YU, Richard Hung Chiu
description	The invention provides a crystalline form of the compound of formula (Ia), methods for making the crystalline form of the compound of formula (Ia), and therapeutic methods for the use of the crystal line form of the compound of formula (Ia). L'invention concerne une forme cristalline du composé de formule (Ia), des procédés de production de la forme cristalline du composé de formule (Ia), et des procédés thérapeutiques pour l'utilisation de la forme cristalline du composé de formule (Ia)
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2017132158A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2017132158A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2017132158A13</originalsourceid><addsrcrecordid>eNqNj0FLAzEQhffSg1j_Q8DLLjRgsq62x2zMkkCSWdKIxmUpReJJtFBvpb_SP-TQ7aFHTzO89_HmzVXxK0NaR2Gt8Yp0EByBjrBFTaM24g0sbWiyTkWdLBlKHhZNqFA74L6uKKdDOZmHgdOyD9ALj2qyFb0MuUdlnMCjFKEVDhARzngY0SwdhF4DdjiRVfschUeCrE7IEbMe6JPptfLJavV6vjFOUSIqAoFIaI00-EucF7OP7ec-35zndXHbqSg1zbvvTd7vtu_5K_9sXoDfsUdWc9YsBav_R_0BKUlTLA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CRYSTALLINE FORM OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-[(METHYL{[2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO]-4-(MORPHOLIN-4-YL)BUTANOYL 9AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE OR COBICISTAT</title><source>esp@cenet</source><creator>YU, Lok Him Lawrence ; LAI, Chiajen ; YU, Richard Hung Chiu</creator><creatorcontrib>YU, Lok Him Lawrence ; LAI, Chiajen ; YU, Richard Hung Chiu</creatorcontrib><description>The invention provides a crystalline form of the compound of formula (Ia), methods for making the crystalline form of the compound of formula (Ia), and therapeutic methods for the use of the crystal line form of the compound of formula (Ia). L'invention concerne une forme cristalline du composé de formule (Ia), des procédés de production de la forme cristalline du composé de formule (Ia), et des procédés thérapeutiques pour l'utilisation de la forme cristalline du composé de formule (Ia)</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170803&DB=EPODOC&CC=WO&NR=2017132158A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170803&DB=EPODOC&CC=WO&NR=2017132158A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YU, Lok Him Lawrence</creatorcontrib><creatorcontrib>LAI, Chiajen</creatorcontrib><creatorcontrib>YU, Richard Hung Chiu</creatorcontrib><title>CRYSTALLINE FORM OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-[(METHYL{[2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO]-4-(MORPHOLIN-4-YL)BUTANOYL 9AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE OR COBICISTAT</title><description>The invention provides a crystalline form of the compound of formula (Ia), methods for making the crystalline form of the compound of formula (Ia), and therapeutic methods for the use of the crystal line form of the compound of formula (Ia). L'invention concerne une forme cristalline du composé de formule (Ia), des procédés de production de la forme cristalline du composé de formule (Ia), et des procédés thérapeutiques pour l'utilisation de la forme cristalline du composé de formule (Ia)</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNj0FLAzEQhffSg1j_Q8DLLjRgsq62x2zMkkCSWdKIxmUpReJJtFBvpb_SP-TQ7aFHTzO89_HmzVXxK0NaR2Gt8Yp0EByBjrBFTaM24g0sbWiyTkWdLBlKHhZNqFA74L6uKKdDOZmHgdOyD9ALj2qyFb0MuUdlnMCjFKEVDhARzngY0SwdhF4DdjiRVfschUeCrE7IEbMe6JPptfLJavV6vjFOUSIqAoFIaI00-EucF7OP7ec-35zndXHbqSg1zbvvTd7vtu_5K_9sXoDfsUdWc9YsBav_R_0BKUlTLA</recordid><startdate>20170803</startdate><enddate>20170803</enddate><creator>YU, Lok Him Lawrence</creator><creator>LAI, Chiajen</creator><creator>YU, Richard Hung Chiu</creator><scope>EVB</scope></search><sort><creationdate>20170803</creationdate><title>CRYSTALLINE FORM OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-[(METHYL{[2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO]-4-(MORPHOLIN-4-YL)BUTANOYL 9AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE OR COBICISTAT</title><author>YU, Lok Him Lawrence ; LAI, Chiajen ; YU, Richard Hung Chiu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2017132158A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>YU, Lok Him Lawrence</creatorcontrib><creatorcontrib>LAI, Chiajen</creatorcontrib><creatorcontrib>YU, Richard Hung Chiu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YU, Lok Him Lawrence</au><au>LAI, Chiajen</au><au>YU, Richard Hung Chiu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CRYSTALLINE FORM OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-[(METHYL{[2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO]-4-(MORPHOLIN-4-YL)BUTANOYL 9AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE OR COBICISTAT</title><date>2017-08-03</date><risdate>2017</risdate><abstract>The invention provides a crystalline form of the compound of formula (Ia), methods for making the crystalline form of the compound of formula (Ia), and therapeutic methods for the use of the crystal line form of the compound of formula (Ia). L'invention concerne une forme cristalline du composé de formule (Ia), des procédés de production de la forme cristalline du composé de formule (Ia), et des procédés thérapeutiques pour l'utilisation de la forme cristalline du composé de formule (Ia)</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre
recordid	cdi_epo_espacenet_WO2017132158A1
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title	CRYSTALLINE FORM OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-[(METHYL{[2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO]-4-(MORPHOLIN-4-YL)BUTANOYL 9AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE OR COBICISTAT
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T22%3A29%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YU,%20Lok%20Him%20Lawrence&rft.date=2017-08-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2017132158A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true